Bain Capital Life Sciences Investors, LLC - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 70 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$71,239,818
-11.8%
3,081,3070.0%7.97%
-4.3%
Q2 2023$80,791,870
+101764.6%
3,081,3070.0%8.32%
-16.1%
Q1 2023$79,313
-36.9%
3,081,307
-36.2%
9.91%
-29.4%
Q4 2022$125,662
-99.9%
4,831,3070.0%14.04%
-14.6%
Q3 2022$137,837,000
+15.9%
4,831,3070.0%16.45%
+17.9%
Q2 2022$118,947,000
-56.4%
4,831,3070.0%13.95%
-47.3%
Q1 2022$272,679,000
-8.9%
4,831,3070.0%26.48%
+11.5%
Q4 2021$299,444,000
-2.3%
4,831,3070.0%23.75%
+24.9%
Q3 2021$306,498,000
-36.2%
4,831,307
-17.1%
19.01%
-39.6%
Q2 2021$480,558,000
+12.0%
5,831,3070.0%31.49%
+29.6%
Q1 2021$429,009,000
-18.8%
5,831,307
-19.9%
24.30%
-26.7%
Q4 2020$528,040,000
+52.1%
7,281,3070.0%33.15%
+2.5%
Q3 2020$347,100,000
+13.5%
7,281,3070.0%32.35%
+1.0%
Q2 2020$305,815,000
+55.6%
7,281,3070.0%32.03%
-3.7%
Q1 2020$196,595,000
-29.9%
7,281,3070.0%33.25%
-20.5%
Q4 2019$280,258,000
+77.5%
7,281,3070.0%41.80%
+2.8%
Q3 2019$157,859,0007,281,30740.64%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 7,281,307$347,100,00032.35%
BVF INC/IL 2,053,991$97,914,0005.33%
Samsara BioCapital, LLC 398,017$18,973,0005.29%
Orbimed Advisors 7,406,307$353,059,0004.44%
Consonance Capital Management LP 602,732$28,732,0003.50%
Boxer Capital, LLC 2,075,905$98,958,0003.42%
Perceptive Advisors 3,481,148$165,946,0002.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,234,262$58,837,0001.43%
DRIEHAUS CAPITAL MANAGEMENT LLC 974,915$46,474,0000.95%
HighVista Strategies LLC 11,477$547,0000.40%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders